Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma

16 Nov 2018

Abstract excerpt

BACKGROUND: Ovarian cancer is the most fatal tumor of the female reproductive system and the fifth leading cause of cancer death among women in the USA. The prognosis is poor due to the lack of biomarkers for treatment options. RESULTS: The methylation array data of 551 patients with ovarian serous cystadenocarcinoma (OSC) in The Cancer Genome Atlas (TCGA) database were assessed in this study to explore the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30446011
DOI: 10.1186/s13148-018-0574-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinomaPMID 30446011Read ↗

Exploration of differential methylation-driven genes to identify key epigenetic genes for prognosis of ovarian serous cystadenocarcinomaSemantic proximity Read ↗

Development and validation of a DNA methylation signature to predict the progression-free survival in patients with advanced-stage ovarian cancerSemantic proximity Read ↗

Epigenetic biomarkers in epithelial ovarian cancer.Semantic proximity Read ↗

Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancerSemantic proximity Read ↗

Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian CancerSemantic proximity Read ↗

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancerSemantic proximity Read ↗

Mining of Subtype Markers for the Prognosis of Ovarian Cancer based on Methylation DataSemantic proximity Read ↗

Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics DataSemantic proximity Read ↗

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behaviorSemantic proximity Read ↗

Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosisSemantic proximity Read ↗

Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data.Semantic proximity Read ↗

Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.